Diabetes UK is working with Healthy Interactions Inc. (Healthyi) to bring diabetes conversation maps to the UK. The three foot by five foot maps roll out flat and feature images and statistics to provide a fun, engaging diabetes education experience. Designed for use in groups of three to ten patients, the maps encourage meaningful discussion about diabetes rather than a one-way lecture. Read more ...
Genaera Corporation (Nasdaq: GENR) announced that the investigational new drug (IND) application submitted to the US Food and Drug Administration (FDA) for trodusquemine (MSI-1436) in type 2 diabetes is now in effect. This application represents the second IND filed by the Company in 2007 for MSI- 1436. A previous IND for the treatment of obesity, under which Genaera is currently conducting phase 1 clinical trials, has been in effect since April 2007. Read more ...
Thursday, January 24, 2008
Subscribe to:
Posts (Atom)
